Transcription of BREZTRI Full Prescribing Information
{{id}} {{{paragraph}}}
HIGHLIGHTS OF Prescribing INFORMATIONT hese highlights do not include all the Information needed to use BREZTRI AEROSPHERE safely and effectively. See full Prescribing Information for BREZTRI AEROSPHERE (budesonide, glycopyrrolate, and formoterol fumarate) inhalation aerosol, for oral inhalation use Initial Approval: 2020------------------------------- INDICATIONS AND USAGE ------------------------------- BREZTRI AEROSPHERE is a combination of budesonide, an inhaled corticosteroid (ICS); glycopyrrolate, an anticholinergic; and formoterol fumarate, a long-acting beta2-adrenergic agonist (LABA), indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
i.e., as rescue therapy for the treatment of acute episodes of bronchospasm. BREZTRI AEROSPHERE has not been studied in the relief of acute symptoms and extra doses should not be used for that purpose. Acute symptoms should be treated with an inhaled short-acting beta. 2-agonist. When beginning treatment with BREZTRI AEROSPHERE, patients who ...
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}